Journal of clinical oncology, 40(4), 382-391. American Society of Clinical Oncology Adenis, A, Kulkarni, A S, Girotto, G C, de la Fouchardiere, C, Senellart, H, van Laarhoven, H W M, Mansoor, W, Al-Rajabi, R, Norquist, J, Amonkar, M, Suryawanshi, S, Bhagia, P & Metges, J-P 2022, ' Impact of Pembrolizumab Versus Chemotherapy as Second-Line Therapy for Advanced Esophageal Cancer on Health-Related Quality of Life in KEYNOTE-181 ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 40, no. 4, pp. 382-391 . https://doi.org/10.1200/JCO.21.00601 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 40(4), 382-391. American Society of Clinical Oncology